Centers for Disease Control and Prevention (CDC) released on November 13, 2019 their report Antibiotic Resistance Threats in the United…

Check out some of the many new features delivered in the QIAGEN CLC solutions QIAGEN CLC Genomics Workbench 20.0: A…

Estimating TMB scores and MSI status using the Biomedical Genomics Analysis plugin for CLC Genomics Workbench In immuno-oncology research, tumor mutation load is…

More mutations, better annotations The Fall 2019 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the…

  Neurofibromatosis (NF) is a genetic disorder that causes tumors to form on nerve tissue. These tumors can develop anywhere…

QIAGEN collaborates with a team from the University of Munich by applying bioinformatics software tools OmicSoft ArrayStudio and Ingenuity Pathway Analysis (IPA) to discover progranulin as a novel and sensitive biomarker for sepsis.

Analysis of microbiome transcriptomes In our recent white paper we describe how to investigate the functional potential of a microbial…

Researchers across the world are using Ingenuity Pathway Analysis to accelerate their work in a variety of applications, including the…

New visualizations for diversity When investigating the composition of microbial communities, researchers often need to calculate and visualize the diversity…

Functional metagenomics analysis of environmental microbiomes: A new white paper for the Microbial Genomics Module of CLC Genomics Workbench Microbiome…

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…

We are happy to announce the Summer ’19 Release of the Human Gene Mutation Database (HGMD) Professional is now available…